SuperSeed Capital Ld - Issue of Equity
RNS Number : 2729M
SuperSeed Capital Limited
11 January 2023

11 January 2023


SuperSeed Capital Limited


("SuperSeed Capital" or the "Company")


Issue of Equity


SuperSeed Capital, a company established as a Venture Capital fund of funds for early-stage technology investing, announces that it will issue and allot 244,240 new ordinary shares of no par value ("Ordinary Shares"), as part of its previously announced investment into Duel, to Creative UK Investments Limited.




Application has been made for the 244,240 new Ordinary Shares, which will rank pari passu with the existing Ordinary Shares in issue, to be admitted to trading on the Aquis Stock Exchange Growth Market ("Admission"). Admission is expected to occur at 8:00 a.m. on, or around, 12 January 2023.


Total Voting Rights 


Following the issue of the 244,240 new ordinary shares, the issued share capital of the Company will be 2,324,240 Ordinary Shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interests in, or changes to their interests in, the Company under the FCA's Disclosure and Transparency Rules.


For more information, please visit or contact:


SuperSeed Capital Limited

+44(0)20 3405 3060

Mads Jensen, Investment Manager


VSA Capital - AQSE Corporate Adviser and Broker

+44(0)20 3005 5000

Corporate Finance: Andrew Raca

Corporate Broking: Andrew Monk, Peter Mattsson, David Scriven


Notes to Editors

SuperSeed Capital Limited was listed on the Aquis Stock Exchange in February 2022 and is a limited partner of SuperSeed Ventures II LP, a venture capital fund managed by SuperSeed Ventures LLP. The Company may also invest directly into unlisted technology companies or in other investment funds managed or advised by SuperSeed Ventures or any affiliate of SuperSeed Ventures or other investment funds managed or advised by third parties other than SuperSeed Ventures.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.